Reduced time to publication and increased rejection rate

Scientific publication: How to handle rejection?

Researchers’ Individual Publication Rate Has Not Increased in a Century

Debates over the pros and cons of a "publish or perish" philosophy have inflamed academia for at least half a century. Growing concerns, in particular, are expressed for policies that reward "quantity" at the expense of "quality," because these might prompt scientists to unduly multiply their publications by fractioning ("salami slicing"), duplicating, rushing, simplifying, or even fabricating ...

Rejection of rejection: a novel approach to overcoming barriers to publication.

All academics aim to publish in high impact journals. However, many leading scientific and medical journals reject more than 80% of the manuscripts they receive, making rejection the biggest barrier to publication in high quality journals. We propose a novel solution to this problem. It involves very little extra work by submitting authors, is applicable to a wide range of circumstances (such a...

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.

BACKGROUND Several multinational controlled clinical trials have shown that triple therapy immunosuppressive regimens which include mycophenolate mofetil (MMF), cyclosporin A (CSA) and steroids (S) are superior compared with conventional regimens which include azathioprine (AZA), CSA and S, mainly because MMF reduces the rate of acute rejection episodes in the first 6 months after kidney transp...

Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.

CONTEXT A successful immunosuppression regimen for combined kidney and pancreas transplants is tacrolimus, mycophenolate mofetil, and prednisone. However, not all patients tolerate these immunosuppressants especially tacrolimus. OBJECTIVE To evaluate the efficacy of cyclosporine as a rescue agent for tacrolimus toxicity in combined kidney and pancreas transplants. DESIGN Retrospective. SE...